BiomarkersHumans
Effects of Processing Deviations on Plasma Concentrations of AD Biomarkers
AAIC 2025 Abstract
Abstract
Background: Blood‐based biomarkers have emerged as a promising tool for detecting the presence of Alzheimer’s disease (AD) pathology in vivo, offering a practical alternative to more costly and invasive biomarker approaches.
The paper
Kate Lange, Victoria J. Williams, Ralph Møller Trane, Sanjay Asthana
Show 14 more authors
Rachael E. Wilson, Ramiro Eduardo Rea Reyes, Beckie Jeffers, Elysse Keske, Cindy Jensen, Aaron Fredricks, Brittani J. Strait, Anne M Fischer, Norma Cooke, Emma Henning, Pamela Herd, Michal Engelman, Sterling C. Johnson, Henrik Zetterberg,University of Wisconsin–Madison
AAIC 2025 Abstract · 23 Dec 2025 · CC BY
Presented at AAIC 2025
